Cover Image

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yuhan Xie, Xue Meng, Tao Li, Haifeng Zhang, Yaonan Zheng, SangYun Kim, Chen Zhang, Xin Yu, Huali Wang
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Plasma amyloid‐β Oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer’s dementia: Findings from the GMCII cohort
by: Yuhan Xie, et al.
Published: (2024)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
by: Marieclaire Overton, et al.
Published: (2025)

Prevalence and predictors of diagnosed mild cognitive impairment among Medicare beneficiaries
by: Elyse Couch, et al.
Published: (2025)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
by: María A. Rodríguez‐Santiago, et al.
Published: (2024)

Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
by: Gustavo Luis Verón, et al.
Published: (2025)

Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
by: Sebastiaan De Keersmaecker, et al.
Published: (2024)

Task‐evoked pupillary responses as potential biomarkers of mild cognitive impairment
by: Julius Opwonya, et al.
Published: (2024)

Real‐world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee‐for‐service beneficiaries
by: Jessie T. Yan, et al.
Published: (2025)

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
by: Adam H. Dyer, et al.
Published: (2025)

Validation of regression‐based change formulae for mild cognitive impairment and Alzheimer's disease
by: Kevin Duff, et al.
Published: (2024)

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography
by: Jacqueline Chua, et al.
Published: (2025)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
by: Sunu Mathew, et al.
Published: (2025)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
by: Xiang‐Sha Yin, et al.
Published: (2025)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
by: Rachel R. Jin, et al.
Published: (2025)

Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort
by: Joyce R. Chong, et al.
Published: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
by: Juliana N. Souza‐Talarico, et al.
Published: (2025)

The prognosis of mild cognitive impairment: A systematic review and meta‐analysis
by: Simone Salemme, et al.
Published: (2025)

Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies
by: Paul C. Donaghy, et al.
Published: (2026)

Correction to “The prognosis of mild cognitive impairment: A systematic review and meta‐analysis”
Published: (2025)

Risk prediction of mild cognitive impairment using electronic health record data
by: Gang Li, et al.
Published: (2025)

Classifying mild cognitive impairment from normal cognition: fMRI complexity matches tau PET performance
by: Kay Jann, et al.
Published: (2025)

The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study
by: Craig Ritchie, et al.
Published: (2025)

Modeling contributions of cognition and apathy to functional impairment in younger‐onset dementia
by: Samuel L. Warren, et al.
Published: (2026)

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
by: Zheng Long Lee, et al.
Published: (2026)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
by: Faheem Arshad, et al.
Published: (2025)

Characterizing Japanese older adults without dementia by amyloid PET status: A comparative study of amyloid‐positive and amyloid‐negative groups from Japanese trial‐ready cohort study
by: Saki Nakashima, et al.
Published: (2026)

Reversal of the concreteness effect can be detected in the natural speech of older adults with amnestic, but not non‐amnestic, mild cognitive impairment
by: Luwen Cao, et al.
Published: (2024)

Social relationships, amyloid burden, and dementia: The ARIC‐PET study
by: Renée C. Groechel, et al.
Published: (2024)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
by: Miguel Ángel Rivas‐Fernández, et al.
Published: (2026)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
by: Ihab Hajjar, et al.
Published: (2024)

Clinical and MRI features associated with amyloid positivity in secondary screening for anti–amyloid‐β therapy
by: Kazuki Yamada, et al.
Published: (2026)

The classification of mild cognitive impairment or healthy ageing improves when including practice effects derived from a semantic verbal fluency task
by: Felix Dörr, et al.
Published: (2025)

Plasma p‐tau217 and cognitive impairment: Evaluating biomarker equity across racial/ethnic groups in HABS‐HD
by: Cellas A. Hayes, et al.
Published: (2026)

Faster decline of very prodromal dementia with Lewy bodies when amyloid positive
by: Frédéric Blanc, et al.
Published: (2025)

Motor, not cognitive, performance relates to amyloid status in normal older adults
by: Amanda Cook Maher, et al.
Published: (2026)

Proteomic profiling identifies serpin G1, ApoA‐II, and LBP as potential biomarkers of dementia in an Egyptian cohort
by: Shimaa A. Heikal, et al.
Published: (2025)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
by: Soheil Mohammadi, et al.
Published: (2025)

White matter hyperintensities in Alzheimer's disease in the era of anti‐amyloid therapies
by: Antoine Garnier‐Crussard, et al.
Published: (2026)

The impact of amyloid beta burden on white matter dysfunction and associated transcriptomic signatures in cognitively normal elderly individuals
by: Ziyun Li, et al.
Published: (2025)

Plasma biomarker‐informed brain topology for cognitive resilience: applications in non‐pharmacological interventions concerning cognitive aging
by: Meishan Ai, et al.
Published: (2026)